GIVAX
PrivateLast Round
Seed
Apr 6, 2022
Total Funding Raised
$12M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GIVAX operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in April 2022.
GIVAX is a biotechnology company developing a novel oral vaccine platform designed to eliminate the burden of preventable GI disease in children and adults.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GIVAX Comparables
Compare GIVAX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vaxart, Inc. | 72% | |
| Esperovax | 72% | |
| VLP Therapeutics | 71% |
For institutional investors. Book with your work email.
GIVAX Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GIVAX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| Kurma Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 29% QoQ, from 14 to 18 employees.
- Jun 21, 2026
Monthly visitors increased 274% MoM.
For institutional investors. Book with your work email.
GIVAX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GIVAX's valuation, stock price, and market status.
Is GIVAX a public or private company?
GIVAX is a private company.
What is the current stock price of GIVAX?
GIVAX is a private company, so its shares have no public market price. Caplight tracks GIVAX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GIVAX worth (valuation)?
Valuation information for GIVAX is not publicly available.
Can I buy GIVAX stock?
GIVAX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GIVAX's last funding round?
GIVAX's most recent funding round was Seed on April 6, 2022.
Who are the main investors in GIVAX?
Key investors in GIVAX include RA Capital Management.
Will GIVAX IPO soon?
No public IPO plans have been announced for GIVAX.
How can I track GIVAX secondary market activity?
Caplight tracks bids, offers, and trades in GIVAX's shares on secondary markets.